Head – International Sales

Date of Joining: 12th December 2012
Experience: 10+ Years in Global Pharmaceutical Business Leadership

Executive Summary:

Mr. Shantanu K. Singh is an accomplished pharmaceutical industry leader with over a decade of hands-on experience in international business development, strategic partnerships, global regulatory compliance, and market expansion. Currently serving as Director of Taj Pharmaceuticals Ltd. and Head of International Sales, Mr. Singh is responsible for driving the organization’s global sales strategy, forging international alliances, and ensuring regulatory excellence across multiple continents.

A key architect of Taj Pharma’s international growth story, Mr. Singh has consistently demonstrated exceptional leadership in establishing Taj Pharma’s presence in over 40+ countries, including the CIS region, Africa, Latin America, Southeast Asia, GCC, and Europe. Under his leadership, Taj Pharma has become a preferred supplier of WHO-GMP-certified pharmaceuticals for ministries of health, public tenders, and global procurement agencies.

Professional Journey:

Mr. Singh joined Taj Pharmaceuticals in 2012, bringing with him a fresh strategic vision focused on global integration, regulatory alignment, and market access. Over the years, he has led major transformational initiatives, including:

  • International Expansion: Successfully launched Taj Pharma’s product portfolio across highly competitive markets including Brazil (ANVISA), Vietnam (MOH), Algeria (LNCPP), Kenya (PPB), UAE (MOHAP), and others.
  • Regulatory Strategy: Instrumental in preparing and managing product registration dossiers across multiple regulatory frameworks including EU-GMP, PICS, WHO-GMP, ANVISA, INVIMA, GCC-DR, TGA, and more.
  • Strategic Alliances: Negotiated and closed long-term contract manufacturing (CMO) and out-licensing deals with multinational and local pharma companies.
  • Institutional Business: Led several successful projects supplying anti-retrovirals, oncology, anti-infectives, and chronic care medicines to UN agencies, government tenders, and NGOs.
  • Portfolio Management: Oversaw product lifecycle management and introduction of niche therapeutic segments including oncology, cardiology, CNS, and orphan drugs.

Areas of Expertise:

  • International Sales & Marketing
  • Regulatory Affairs & Product Registration
  • Institutional & Government Business
  • Contract Manufacturing (CMO/CDMO)
  • Licensing & Out-Licensing
  • Business Development & Strategic Planning
  • Market Access & Pharmacoeconomics
  • Tender Participation (Global Fund, MOH Procurement)
  • Pharmacovigilance & Post-Marketing Surveillance (PMS)

Key Achievements:

  • Expanded Taj Pharma’s export business footprint to over 40+ international markets within a decade.
  • Played a leading role in setting up regulatory-compliant supply chains for oncology injectables, lyophilized formulations, hormonal therapies, and orphan drugs.
  • Developed and implemented a multi-tier distribution model to penetrate both retail and institutional markets in East and West Africa.
  • Supported dossier submission and GMP audits for over 400+ product registrations in stringent and semi-regulated markets.
  • Spearheaded business transformation projects to align Taj Pharma with Digital Pharma 4.0 practices, improving CRM, documentation, and project tracking systems.

Leadership Style & Vision:

Mr. Shantanu K. Singh is known for his collaborative leadership, data-driven decision-making, and a deep commitment to access to affordable healthcare. His vision is anchored in aligning Taj Pharma’s mission with global public health needs, particularly in low- and middle-income countries (LMICs), where quality generics and essential medicines can dramatically improve lives.

He has earned respect across the industry for his ability to combine regulatory insight with commercial strategy, enabling Taj Pharma to deliver value-driven, patient-centric solutions in even the most challenging environments.

Future Focus:

  • Expand Taj Pharma’s direct presence in Latin America and West Africa through joint ventures and local partnerships.
  • Drive biotechnology and biosimilars roadmap for Taj Pharma’s future portfolio.
  • Strengthen global pharmacovigilance systems to meet evolving regulatory standards.
  • Promote technology transfer and technical collaboration with foreign manufacturing partners.
  • Advocate for public-private partnerships (PPP) in pharmaceutical supply chain ecosystems.

Personal Attributes:

  • Fluent in English and proficient in French and Spanish business communication.
  • Passionate about global health policy and pharmaceutical accessibility.
  • Known for meticulous planning, strong negotiation skills, and high ethical standards.
  • Actively participates in international pharmaceutical trade fairs, WHO and MOH delegation meets, and investor summits.

Mr. Shantanu K. Singh’s leadership has been pivotal in shaping Taj Pharmaceuticals into a globally trusted brand known for quality, compliance, and affordability. With over ten years of dedicated service, his contributions continue to empower Taj Pharma to bridge therapeutic gaps worldwide—delivering hope, healing, and high-quality medicine to millions.